FATE Aug 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 12:30PM EDT
| Previous close | 0.4300 |
| Open | 0.4600 |
| Bid | 0.3000 |
| Ask | 0.6500 |
| Strike | 5.00 |
| Expiry date | 2024-08-16 |
| Day's range | 0.4300 - 0.4800 |
| Contract range | N/A |
| Volume | |
| Open interest | 164 |
Simply Wall St.Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
Fate Therapeutics ( NASDAQ:FATE ) First Quarter 2024 Results Key Financial Results Net loss: US$48.0m (loss widened by...
- GuruFocus.com
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...
Despite Revenue Growth, Losses Widen; Clinical Trials Progress in Autoimmune and Cancer Treatments
ZacksFate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.